Lovastatin for adult patients with dengue: protocol for a randomised controlled trial
BACKGROUND: Dengue is the most important vector-borne viral infection of man, with approximately 2 billion people living in areas at risk. Infection results in a range of manifestations from asymptomatic infection through to life-threatening shock and haemorrhage. One of the hallmarks of severe deng...
Saved in:
| Main Author: | |
|---|---|
| Format: | Journal Article |
| Language: | English |
| Published: |
2018
|
| Online Access: | https://demo7.dspace.org/handle/123456789/189 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Lovastatin for adult patients with dengue: protocol for a randomised controlled trial
- Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial
- Randomised Controlled Clinical Trials
- A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients
- A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
- Effects of Short-Course Oral Corticosteroid Therapy in Early Dengue Infection in Vietnamese Patients: A Randomized, Placebo-Controlled Trial
- Considerations in the Design of Clinical Trials to Test Novel Entomological Approaches to Dengue Control